Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
filingDate |
2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1c28aa286da4fb3134c008c8489994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ece2b6beadeee5ecfe19b1fe06a74c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0343e7362de12c545e4f502143be2a40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c62054659e58b2ee956906e13bfeb20 |
publicationDate |
2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019038737-A1 |
titleOfInvention |
USE OF CANAKINUMAB |
abstract |
The present invention relates to canakinumab for use in reducing the risk or prevention of recurrent cardiovascular events (CV) in a patient with high hsCRP who has suffered from myocardial infarction (MI). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3761991-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022023907-A1 |
priorityDate |
2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |